| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 01/27/2005 | US20050020521 In vivo gene silencing by chemically modified and stable siRNA |
| 01/27/2005 | CA2532805A1 Pharmaceutical composition |
| 01/26/2005 | EP1499609A2 Pesticidal heterocycles |
| 01/26/2005 | EP1427727B1 Compounds which inhibit the release of inflammatory cytokines |
| 01/26/2005 | EP0958514B1 Novel photochromic heterocyclic fused indenonaphthopyrans |
| 01/26/2005 | CN1571789A Himbacine analogues as thrombin receptor antagonists |
| 01/26/2005 | CN1571774A Pyrimidinones as melanin concentrating hormone receptor 1 |
| 01/26/2005 | CN1569870A Nucleotide analogs with six-membered rings |
| 01/26/2005 | CN1186346C Thienopyrrolidinones |
| 01/25/2005 | US6846839 Identifying indolinone compounds that inhibit growth factor stimulated cell proliferation by contacting cells with compounds and with selected growth factors and monitoring inhibitory effect |
| 01/25/2005 | US6846819 Bactericides compound containing acrylamide group |
| 01/20/2005 | WO2005004875A1 Medicinal composition for pulmonary administration |
| 01/20/2005 | WO2004099145A3 Phenyl substituted cyclic derivatives |
| 01/20/2005 | US20050014793 Pyridinone derivatives for treatment of atherosclerosis |
| 01/20/2005 | US20050014771 fused thienopyrimidine compounds useful as phosphatidylinositol 3-kinase inhibitors and carcinostatic agents |
| 01/20/2005 | US20050014769 Anticancer agents; controlling apoptosis |
| 01/19/2005 | EP1497296A1 1,4 DIAZOCINO 7,8,1-hi INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS |
| 01/19/2005 | EP1230244B1 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 01/19/2005 | EP1089988A4 Fluorophenyl resin compounds |
| 01/19/2005 | CN1566116A Process for preparing wedelia lactone and application thereof |
| 01/19/2005 | CN1185259C Fluorophenyl resin compounds |
| 01/13/2005 | WO2005003140A1 4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents |
| 01/13/2005 | WO2005003139A1 Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug |
| 01/13/2005 | WO2005003138A2 Process for the preparation of amorphous form of a platelet aggregation inhibitor drug |
| 01/13/2005 | WO2005003132A1 Perylenetetracarboxylic acid dibenzimidazole sulfoderivatives containing oxo-groups in the perylene core which form part of a para-quinoid system of bonds, lyotropic liquid crystal systems and anisotropic films containing the same, and methods for making the same |
| 01/13/2005 | WO2005003128A1 Thiazolylpiperidine derivatives as mtp inhibitors |
| 01/13/2005 | WO2005003126A1 Photochromic diarylethene-containing coordination compounds and the production thereof |
| 01/13/2005 | WO2005002577A1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 01/13/2005 | WO2004096805A3 Lyotropic liquid crystal systems based on sulfonated perylenetetracarboxylic acid dibenzimidazoles |
| 01/13/2005 | WO2004064764A3 Substituted alkyl amido piperidines |
| 01/13/2005 | WO2003102592A3 Selective binding and analysis of macromolecules: quantitative analysis of proteins in complex mixtures |
| 01/13/2005 | US20050009874 Tetrahydropyridin or piperidino heterocyclic derivatives |
| 01/13/2005 | US20050009855 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives; these compounds interfere with the E1-E2-DNA complex during initiation of DNA replication |
| 01/13/2005 | US20050009845 Thienopyrimidine compounds as protein tyrosine kinase inhibitors |
| 01/13/2005 | US20050009829 1-Substituted 2-carboxamide derivatives of fused ring imidazoles, e.g., -[5-(5-Chloro-thiophen-2-yl)-isoxazol-3-ylmethyl]-1H-benzoimidazole-2-carboxylic acid (1-isopropyl-piperidin-4-yl)-amide |
| 01/13/2005 | US20050009823 E.g., derivatives of pyrazolo[1,5-a]pyrimidines; [1,2,3]triazolo[4,5-b]pyridines; and pyrrolo[3,2-d]pyrimidines and their use as corticotropin releasing factor antagonists |
| 01/13/2005 | US20050008568 Complex containing dithiocarbamate compound |
| 01/13/2005 | CA2530886A1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 01/13/2005 | CA2530446A1 Process for the preparation of amorphous form of a platelet aggregation inhibitor drug |
| 01/12/2005 | EP1495768A1 Preventives/remedies for hotflash |
| 01/12/2005 | EP1495002A1 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/12/2005 | EP1494997A1 Substituted aryl amides |
| 01/12/2005 | CN1564813A Intermediate for biotin and process for producing the same |
| 01/11/2005 | US6841684 Imidiazoles having reduced side effects |
| 01/11/2005 | US6841677 For use as semiconductors or charge transport materials in optical, electrooptical or electronic devices including field effect transistors, electroluminescent, photovoltaics, sensors and electrophotographic recording devices |
| 01/11/2005 | US6841566 Viral polymerase inhibitors |
| 01/11/2005 | US6841553 Contorlling fertility |
| 01/06/2005 | WO2005000828A1 Quinone based compound, photosensitive article for electrophotography and electrophotographic device using the same |
| 01/06/2005 | WO2005000293A1 Therapeutic agent for overactive bladder accompanying cerebrovascular disorder |
| 01/06/2005 | US20050004203 NAALADase inhibitors; effecting transforming growth factor beta or neuronal activity |
| 01/06/2005 | US20050004166 Imino acid derivatives as inhibitors of matrix metalloproteinases |
| 01/06/2005 | US20050004161 Herpes simplex, varicella zoster, cytomegalo, Epstein Barr |
| 01/06/2005 | US20050004143 Bi-cyclic pyrimidine inhibitors of TGFbeta |
| 01/06/2005 | US20050004142 furo(2,3-d)pyrimidine and thieno(2,3-d)pyrimidine compounds for treating cancer and hyperproliferative diseases; receptor tyrosine kinase inhibitors |
| 01/06/2005 | US20050004126 Method of determining potential allosterically-binding matrix metalloproteinase inhibitors |
| 01/06/2005 | US20050004124 Synergistic mixture; antidiabetic agents; antiischemic agents |
| 01/06/2005 | US20050004110 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 01/06/2005 | US20050004099 Spiroazabicyclic heterocyclic compounds |
| 01/06/2005 | US20050004078 Nucleotide analogs with six-membered rings |
| 01/06/2005 | US20050004039 Selective analgesic agents |
| 01/06/2005 | US20050001202 Perylenetetracarboxylic acid dibenzimidazole sulfoderivatives containing oxo-groups in the perylene core which form part of a para-quinoid system of bonds, lyotropic liquid crystal systems and anisotropic films containing the same, and methods for making the same |
| 01/05/2005 | EP1493743A1 Substituted bipiperidine intermediates and derivatives thereof |
| 01/05/2005 | EP1492795A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 01/05/2005 | EP1492794A1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders |
| 01/05/2005 | EP1492783A1 4,5,6,7-tretrahydrobenzo(b) thiophene derivatives and methods for medical intervention against mycrobacterial infections |
| 01/05/2005 | EP1492595A1 Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist |
| 01/05/2005 | EP1492571A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 01/05/2005 | EP1133300B1 Desmethylolanzapine compositions and methods |
| 01/05/2005 | CN1183129C Condensed azepines as vasporession agonists |
| 01/04/2005 | US6838477 Lactacystin analogs |
| 01/04/2005 | US6838457 Fused heteroaryl derivatives |
| 12/30/2004 | DE10326386A1 N-Heterocyclyl-phenylsubstituierte cyclische Ketoenole N-heterocyclyl-substituted cyclic ketoenols |
| 12/29/2004 | WO2004113391A2 Improved pharmaceutical drug candidates and methods for preparation thereof |
| 12/29/2004 | WO2004113362A2 Libraries containing heterocyclic organic molecules prepared through intramolecular formation of n-acyliminium ions |
| 12/29/2004 | WO2004113349A1 Process for preparing 3-aminothienopyridone derivatives |
| 12/29/2004 | WO2004113348A1 Thienopyridone derivatives as kinase inhibitors |
| 12/29/2004 | WO2004113347A1 Thienopyridone derivatives as kinase inhibitors |
| 12/29/2004 | WO2004113346A1 Novel amorphous form |
| 12/29/2004 | WO2004113345A1 Fused pyrrole compound and medicinal use thereof |
| 12/29/2004 | WO2004112714A2 Chemical compounds |
| 12/29/2004 | WO2004078119A3 Substituted thiophenes with antibacterial activity |
| 12/29/2004 | EP1491541A1 Pyridazinone aldose reductase inhibitors |
| 12/29/2004 | EP1491540A1 Pyridazinone aldose reductase inhibitors |
| 12/29/2004 | EP1491353A1 Optical recording media and dipyrromethene-metal chelate compounds |
| 12/29/2004 | EP1490374A2 Dithiolopyrrolone derivatives useful in the treatment of proliferative diseases |
| 12/29/2004 | EP1490371A1 Thiopene-based tricyclic compounds and pharmaceutical compositions comprising same |
| 12/29/2004 | EP1490344A2 Anxiolytic agents with reduced sedative and ataxic effects |
| 12/29/2004 | EP1490058A1 Peroxisome proliferator activated receptor modulators |
| 12/29/2004 | EP1490048A1 Pharmaceutical composition for preventing or treating respiratory disease |
| 12/29/2004 | EP1373259B1 Pyridazinone aldose reductase inhibitors |
| 12/29/2004 | EP1226138B1 Fab i inhibitors |
| 12/29/2004 | CN1182123C Substituted bicyclic derivatives useful as anticancer agents |
| 12/29/2004 | CA2533480A1 Libraries containing heterocyclic organic molecules prepared through intramolecular formation of n-acyliminium ions |
| 12/29/2004 | CA2528927A1 Process for preparing 3-aminothienopyridone derivatives |
| 12/29/2004 | CA2528603A1 Thienopyridone derivatives as kinase inhibitors |
| 12/29/2004 | CA2528602A1 Thienopyridone derivatives as kinase inhibitors |
| 12/29/2004 | CA2528538A1 Dual function compounds and uses thereof |
| 12/28/2004 | CA2226039C Pyridylfuran and pyridylthiophene compounds |
| 12/28/2004 | CA2105923C 7-isoindolinyl-quinolone derivatives and 7-isoindolinyl-naphthyridone derivatives |
| 12/23/2004 | WO2004111058A1 Heteroryl-fused pyrimidinyl compounds as anticancer agents |